Healthcare Capital Overview
Valuation check: HCCC's ROE is -15.45%, below the sector sector average of -5.87%.
Get informed when a big investor buys or sells
+ Follow-15.45%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Healthcare Capital (HCCC) currently reports a ROE of -15.45%. That is below the sector sector average of -5.87%. Use the charts on this page to explore Healthcare Capital's ROE history and peer comparisons.
Healthcare Capital's ROE of -15.45% is lower than the its sector sector average of -5.87%. That is roughly 163.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Healthcare Capital's current -15.45% should be judged against industry norms (sector average: -5.87%) and against HCCC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -15.45%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.87%. From there, open related valuation or income-statement pages for Healthcare Capital, and consider following HCCC for alerts when major investors trade the stock.
